MedPath

Diffusion Weighted MRI Accuracy in Cholesteatoma Localization

Conditions
Cholesteatoma
Registration Number
NCT03915392
Lead Sponsor
University Hospital, Strasbourg, France
Brief Summary

Magnetic resonance imaging of the middle ear has an increasing place in the therapeutic strategy in otology and especially for cholesteatoma. It is currently performed for complicated cholesteatomas and as part of the follow-up of operated patients to detect a recurrence or a cholesteatoma residue (alternative of choice to "second look" surgery). Some people take CT and MRI fusion to improve the localization of cholesteatoma. Many studies have investigated the diagnostic capabilities of MRI but very few have demonstrate their reliability in location diagnosis. The aim of the study was to propose a topographic reading method of the MRI of the middle ear and to evaluate the performances in the localization of the cholesteatoma in order to adapt the surgical management

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
MRI imaging study to locate cholesteatoma.The period from January 1st, 2010 to Dcember 31, 2017 will be examined
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Service D'Orl Et de Chirurgie Cervico-Faciale

🇫🇷

Strasbourg, France

Service D'Orl Et de Chirurgie Cervico-Faciale
🇫🇷Strasbourg, France
Anne CHARPIOT, MD, PhD
Principal Investigator
Antoine MERANGER, MD
Sub Investigator
Francis VEILLON, MD, PhD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.